-
STTT | Breakthrough in Kidney Cancer by Academician Xu Zhang’s Team! Neoadjuvant Regimen of Toripalimab Combined with Axitinib Assists RCC Patients with Tumor Thrombus Downstaging
Radical nephrectomy combined with venous tumor thrombus resection is the preferred treatment for renal cell carcinoma (RCC) with inferior vena cava tumor thrombus (IVC-TT) and can significantly improve patient prognosis. Preoperative neoadjuvant therapy aimed at reducing tumor thrombus level and grade is of great importance in reducing perioperative risks. Recently, the NEOTAX study, led by…
-
Dr. Jiuda Zhao’s Study in JCO Highlights Electroacupuncture’s Impact on Triple Antiemetic Therapy for Chemotherapy
Research Title: Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial Dr. Jiuda Zhao：This is the first study to integrate…
-
Dr. Jiuda Zhao Publishes Breakthrough Study in JCO, Demonstrating Electroacupuncture’s Significant Impact on Triple Antiemetic Therapy for Highly Emetogenic Chemotherapy
Recently, the team led by Dr. Jiuda Zhao at the Breast Disease Diagnosis and Treatment Center of Qinghai University Affiliated Hospital published their latest research findings in the Journal of Clinical Oncology (JCO), with an impact factor of 42.10. This study is the first to combine the current standard triple antiemetic therapy with electroacupuncture (EA)…
-
CSCO 2024 | Dr. Feng Shen: Witnessing CSCO’s Glorious Journey, Contributing to the Advancement of Personalized Surgical Treatment for Hepatobiliary Tu
Growing Together with CSCO Witnessing the Glorious Growth of CSCO and Contributing to the Development of the Hepatocellular Carcinoma Expert Committee Dr. Feng Shen: My mentor, Academician Wu Mengchao, was…
-
Dr. Yuan Yu’s Insights: Advances in Esophageal Cancer Nursing and Future Directions for Enhanced Recovery | CACA Integrated Esophageal Cancer Academic
Oncology Frontier: During the conference’s esophageal cancer integrated nursing session, you gave a talk on recent research advancements in the field of esophageal cancer nursing. Could you share some of…
-
Minimally Invasive Surgery and Immunotherapy Dr. Yongde Liao Discusses New Pathways in Esophageal Cancer Treatment | CACA Integrated Esophageal Cancer
Oncology Frontier: You have extensive experience in minimally invasive surgery for esophageal cancer. How do you evaluate the effectiveness and safety of minimally invasive surgery? What clinical factors do you…
-
CSCO 2024: Dr. Zhiming Li Champions New Frontiers in Lymphoma Management
From September 25 to September 29, the 27th National Clinical Oncology Conference and CSCO Annual Meeting, organized by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Xisike Clinical Oncology Research Foundation, was successfully held in Xiamen. During the conference, Hematology Frontier invited Dr. Zhiming Li from Sun Yat-sen University Cancer Center to share…
-
CAR-T vs. Bispecific Antibodies: Dr. Junmin Song’s Groundbreaking Myeloma Study at ESMO 2024
The 2024 Annual Meeting of the European Society for Medical Oncology (ESMO) was recently held in Barcelona, Spain. As one of the premier global oncology conferences, it brought together experts and scholars from around the world to share cutting-edge research and chart future directions. During the conference, Dr. Junmin Song from the Jacobi Medical Center,…
Connecting Medical Expertise through Media